K-reading
Showing 1 - 25 of 3,508
Refractive Errors Trial in Hong Kong (3000K Reading lamp, 4500K Reading lamp, 6500K Reading lamp)
Recruiting
- Refractive Errors
- 3000K Reading lamp
- +2 more
-
Hong Kong, Kowloon, Hong KongOptometry Research Clinic
Feb 14, 2023
Presbyopia Trial in Dhaka (Glasses to correct presbyopia)
Not yet recruiting
- Presbyopia
- Glasses to correct presbyopia
-
Dhaka, Bir Uttom A K Khandakar Road, BangladeshJames P. Grant School of Public Health BRAC University
Aug 19, 2022
Age-related Macular Degeneration, Dementia, Low Vision Trial in Longueuil, Montreal (Low Vision Reading Rehabilitation)
Suspended
- Age-related Macular Degeneration
- +6 more
- Low Vision Reading Rehabilitation
-
Longueuil, Quebec, Canada
- +1 more
Mar 14, 2021
Alzheimer's Disease, Dementia, Brain Diseases Trial in Italy, United Kingdom, United States (Donanemab, Placebo)
Not yet recruiting
- Alzheimer's Disease
- +7 more
- Donanemab
- Placebo
-
Chandler, Arizona
- +51 more
Feb 13, 2023
Coronary Artery Disease Trial in Canada, United States (Hybrid Coronary Revascularization (isolated LIMA-LAD), Hybrid Coronary
Completed
- Coronary Artery Disease
- Hybrid Coronary Revascularization (isolated LIMA-LAD)
- +2 more
-
Long Beach, California
- +45 more
May 25, 2022
Developmental Dyslexia Trial in Roma (Active HD-tDCS over V5/MT, Active HD-tDCS over V1, Sham HD-tDCS over V5/MT or V1)
Recruiting
- Developmental Dyslexia
- Active HD-tDCS over V5/MT
- +2 more
-
Roma, ItalyBambino Gesù Hospital and Research Institute
Aug 2, 2023
Hip Fractures Trial in Canada, United States (Regional Anesthesia, General Anesthesia)
Active, not recruiting
- Hip Fractures
- Regional Anesthesia
- General Anesthesia
-
Birmingham, Alabama
- +44 more
Jan 7, 2022
Developmental Dyslexia Trial in Roma (Active tDCS, Active tRNS, Sham tRNS or tDCS)
Enrolling by invitation
- Developmental Dyslexia
- Active tDCS
- +2 more
-
Roma, ItalyBambino Gesù Hospital and Research Institute
Apr 14, 2023
EEG Trial in Montreal (Set For Variability, Current Best Practices)
Recruiting
- EEG
- Set For Variability
- Current Best Practices
-
Montreal, Quebec, CanadaMcGill University
Sep 23, 2022
Autism Spectrum Disorder Trial in Lawrence (More Social Stories, Less Social Stories)
Recruiting
- Autism Spectrum Disorder
- More Social Stories
- Less Social Stories
-
Lawrence, KansasUniversity of Kansas Comprehension and Language Learning Lab
Oct 30, 2023
Language Disorders in Children Trial in Boston, Columbus (Let's Know! small-group or TierL 2 Intervention)
Recruiting
- Language Disorders in Children
- Let's Know! small-group or TierL 2 Intervention
-
Boston, Massachusetts
- +1 more
Nov 9, 2022
Acute Leukemia, Advanced Solid Tumor Trial in Gent (Bibliotherapy)
Recruiting
- Acute Leukemia
- Advanced Solid Tumor
- Bibliotherapy
-
Gent, Oost-Vlaanderen, BelgiumUniversitair Ziekenhuis Gent
Dec 8, 2022
Crohn's Disease Trial in Worldwide (Enhanced Treatment Algorithm, Conventional Step-care Algorithm)
Completed
- Crohn's Disease
- Enhanced Treatment Algorithm
- Conventional Step-care Algorithm
-
Washington, District of Columbia
- +21 more
Nov 4, 2021
Low Vision, Low Vision Aids Trial in United States (Low Vision Rehabilitation)
Recruiting
- Low Vision
- Low Vision Aids
- Low Vision Rehabilitation
-
Fullerton, California
- +9 more
Oct 24, 2023
Sjogren's Syndrome Trial in Worldwide (Placebo, Nipocalimab, Standard of Care Treatment)
Recruiting
- Sjogren's Syndrome
- Placebo
- +2 more
-
Anniston, Alabama
- +77 more
Aug 18, 2022
Low Vision Trial in Los Angeles (Socially Assistive Robot for Low Vision Rehabilitation)
Recruiting
- Low Vision
- Socially Assistive Robot for Low Vision Rehabilitation
-
Los Angeles, CaliforniaUCLA Stein Eye Institute
Sep 1, 2022
Language Development Trial in Santo Domingo, Desamparados (Interactive Book Reading)
Active, not recruiting
- Language Development
- Interactive Book Reading
-
Santo Domingo, Heredia, Costa Rica
- +1 more
Jun 6, 2022
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States
Completed
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +44 more
Jan 10, 2022
Pancreatic Cancer Non-resectable Trial in Worldwide (Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX,
Active, not recruiting
- Pancreatic Cancer Non-resectable
- Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
- Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX
-
Phoenix, Arizona
- +89 more
Dec 22, 2022
Artificial Intelligence in Breast Cancer Screening in Region
Completed
- Breast Cancer
- AI cancer detection system
-
Linköping, Östergötland, SwedenRegion Östergötland
Apr 19, 2022
Problem Behavior Trial in Malmö (Good Behavior Game)
Completed
- Problem Behavior
- Good Behavior Game
-
Malmö, Sweden
- +4 more
Mar 31, 2023
Clinical Effectiveness of iReadMore for People With Alexia
Recruiting
- Stroke
- +4 more
- iReadMore
-
London, United KingdomInstitute of Neurology, University College London
May 17, 2022
Reading Trial in Stanford (Reading and Growth Mindset, Wait-list Control)
Recruiting
- Reading
- Reading and Growth Mindset
- Wait-list Control
-
Stanford, CaliforniaStanford University
Jan 20, 2022
Crohn Disease, Remission Trial in Worldwide (5-ASA Withdrawal)
Recruiting
- Crohn Disease
- Remission
- 5-ASA Withdrawal
-
Calgary, Alberta, Canada
- +45 more
Apr 1, 2021